XNCR Stock: Price, Earnings History and SEC Filings
Xencor, Inc. (XNCR) last traded at $29.82, up 2.09% on the latest session and up 19.5% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.29 against an analyst estimate of $-0.82, a beat of 64.6%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
XNCR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $-0.29 | $-0.82 | +64.63% |
| Mar 2026 | May 6, 2026 | $-1.71 | $-0.65 | -163.08% |
| Dec 2025 | Feb 25, 2026 | $-0.09 | $-0.64 | +85.94% |
| Sep 2025 | Nov 5, 2025 | $-0.08 | $-0.72 | +88.89% |
XNCR beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How XNCR reacts to earnings
Across its last 8 earnings releases, XNCR moved 6.9% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-26 | Before open | +15.89% |
| 2026-08-05 | After close | +0.81% |
| 2026-07-29 | After close | +10.04% |
| 2026-05-06 | After close | -5.38% |
| 2026-02-25 | After close | +13.11% |
| 2026-01-08 | Before open | -5.08% |
| 2025-11-05 | After close | -2.57% |
| 2025-08-06 | After close | -2.27% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
XNCR financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $126M | -$92M | -$138M | -73.2% | $-1.24 |
| 2024 | $110M | -$233M | -$208M | -210.5% | $-3.58 |
| 2023 | $175M | -$133M | -$96M | -76.2% | $-2.20 |
| 2022 | $165M | -$55M | -$14M | -33.5% | $-0.93 |
| 2021 | $275M | $83M | -$30M | 30.0% | $1.37 |
| 2020 | $123M | -$69M | -$16M | -56.5% | $-1.21 |
| 2019 | $157M | $27M | $57M | 17.2% | $0.46 |
| 2018 | $41M | -$70M | -$87M | -173.4% | $-1.31 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for XNCR
- 8-K · Oct 26, 2026Results of operations, Regulation FD disclosure, Other events
- 10-Q · Aug 5, 2026
- 8-K · Aug 5, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 29, 2026Material agreement, Results of operations, Regulation FD disclosure
- 8-K · Jun 18, 2026Shareholder vote
- 10-Q · May 6, 2026
- 8-K · May 6, 2026Results of operations, Financial statements and exhibits
- 8-K · May 5, 2026Regulation FD disclosure, Financial statements and exhibits
- DEF 14A · Apr 27, 2026
- 8-K · Apr 27, 2026Officer or director change, Financial statements and exhibits
Insider filing activity
XNCR insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
XNCR news
- Xencor Sees Upside Potential After 'Exciting' Kidney Cancer Trial Data, RBC Capital Markets SaysOct 27, 2026 · finance.yahoo.com
- Xencor (XNCR) Is Up 15.8% What's Changed After Kidney Cancer Trial UpdateOct 26, 2026 · finance.yahoo.com
- Xencor Catapults On 'Unprecedented,' 'Profound' Cancer DataOct 26, 2026 · finance.yahoo.com
- Xencor Picks Phase 3 Dose After XmAb819 Shows 45.5% Response Rate in Kidney CancerOct 26, 2026 · marketbeat.com
- Xencor Soars 31% on Kidney Cancer Trial Data Showing “Impressive Antitumor Activity”Oct 26, 2026 · tikr.com
- Sector Update: Healthcare Stocks Softer Monday AfternoonOct 26, 2026 · finance.yahoo.com
- Top Midday GainersOct 26, 2026 · finance.yahoo.com
- Xencor shares jump as kidney cancer drug data support Phase 3 plansOct 26, 2026 · proactiveinvestors.com
About Xencor, Inc.
Xencor, Inc. (XNCR) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in DE. Its fiscal year ends in December.